These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
881 related articles for article (PubMed ID: 30472188)
21. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1. Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539 [TBL] [Abstract][Full Text] [Related]
22. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling. Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346 [TBL] [Abstract][Full Text] [Related]
23. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development. Rozengurt E; Eibl G World J Gastroenterol; 2019 Apr; 25(15):1797-1816. PubMed ID: 31057295 [TBL] [Abstract][Full Text] [Related]
24. Hypoxic conditions differentially regulate TAZ and YAP in cancer cells. Yan L; Cai Q; Xu Y Arch Biochem Biophys; 2014 Nov; 562():31-6. PubMed ID: 25078107 [TBL] [Abstract][Full Text] [Related]
25. Metabolic control of YAP and TAZ by the mevalonate pathway. Sorrentino G; Ruggeri N; Specchia V; Cordenonsi M; Mano M; Dupont S; Manfrin A; Ingallina E; Sommaggio R; Piazza S; Rosato A; Piccolo S; Del Sal G Nat Cell Biol; 2014 Apr; 16(4):357-66. PubMed ID: 24658687 [TBL] [Abstract][Full Text] [Related]
26. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation. Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853 [TBL] [Abstract][Full Text] [Related]
27. TAZ and YAP are frequently activated oncoproteins in sarcomas. Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148 [TBL] [Abstract][Full Text] [Related]
28. Identification of Prolyl isomerase Pin1 as a novel positive regulator of YAP/TAZ in breast cancer cells. Khanal P; Yeung B; Zhao Y; Yang X Sci Rep; 2019 Apr; 9(1):6394. PubMed ID: 31015482 [TBL] [Abstract][Full Text] [Related]
29. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis. Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452 [TBL] [Abstract][Full Text] [Related]
30. Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ. Escoll M; Gargini R; Cuadrado A; Anton IM; Wandosell F Oncogene; 2017 Jun; 36(25):3515-3527. PubMed ID: 28166194 [TBL] [Abstract][Full Text] [Related]
31. CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling. Wang S; Englund E; Kjellman P; Li Z; Ahnlide JK; Rodriguez-Cupello C; Saggioro M; Kanzaki R; Pietras K; Lindgren D; Axelson H; Prinz CN; Swaminathan V; Madsen CD Nat Cell Biol; 2021 Jul; 23(7):758-770. PubMed ID: 34226698 [TBL] [Abstract][Full Text] [Related]
32. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway. Jang JW; Kim MK; Bae SC Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552 [TBL] [Abstract][Full Text] [Related]
33. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity. Liu J; Ye L; Li Q; Wu X; Wang B; Ouyang Y; Yuan Z; Li J; Lin C J Pathol; 2018 Jan; 244(1):71-83. PubMed ID: 28991374 [TBL] [Abstract][Full Text] [Related]
34. Integrin signalling regulates YAP and TAZ to control skin homeostasis. Elbediwy A; Vincent-Mistiaen ZI; Spencer-Dene B; Stone RK; Boeing S; Wculek SK; Cordero J; Tan EH; Ridgway R; Brunton VG; Sahai E; Gerhardt H; Behrens A; Malanchi I; Sansom OJ; Thompson BJ Development; 2016 May; 143(10):1674-87. PubMed ID: 26989177 [TBL] [Abstract][Full Text] [Related]
35. YAP/TAZ for cancer therapy: opportunities and challenges (review). Guo L; Teng L Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178 [TBL] [Abstract][Full Text] [Related]
36. YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer. Horie M; Saito A; Ohshima M; Suzuki HI; Nagase T Cancer Sci; 2016 Dec; 107(12):1755-1766. PubMed ID: 27627196 [TBL] [Abstract][Full Text] [Related]
37. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis. Li H; Gumbiner BM Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049 [TBL] [Abstract][Full Text] [Related]
38. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501 [TBL] [Abstract][Full Text] [Related]
39. The novel YAP target gene, SGK1, upregulates TAZ activity by blocking GSK3β-mediated TAZ destabilization. Yoo G; Kim T; Chung C; Hwang DS; Lim DS Biochem Biophys Res Commun; 2017 Aug; 490(3):650-656. PubMed ID: 28634071 [TBL] [Abstract][Full Text] [Related]
40. Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability. Kim Y; Kim W; Song Y; Kim JR; Cho K; Moon H; Ro SW; Seo E; Ryu YM; Myung SJ; Jho EH Proc Natl Acad Sci U S A; 2017 May; 114(18):4691-4696. PubMed ID: 28416659 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]